View Older Stories View More Recent Stories

Jul 24, 2023 08:00AM Baxter Launches PERCLOT Absorbable Hemostatic Powder
Jul 18, 2023 04:15PM Baxter Declares Quarterly Dividend
Jul 17, 2023 08:00PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
Jun 29, 2023 04:16PM Baxter (BAX) Appoints William Ampofo to Its Board
Jun 29, 2023 04:15PM Baxter Appoints William Ampofo to Its Board
Jun 29, 2023 09:00AM Baxter Launches Progressa+ Next Gen ICU Bed to Help Address Complex Critical Care Needs
Jun 26, 2023 08:30AM Baxter Publishes Annual Corporate Responsibility Report, Reinforcing Longstanding Commitment to Making a Meaningful Difference
Jun 20, 2023 08:30AM Nuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Jun 13, 2023 04:30PM Baxter to Host Second-Quarter 2023 Financial Results Conference Call for Investors
Jun 13, 2023 04:15PM Nuwellis to Participate in the Maxim Group Virtual Healthcare Conference
Jun 5, 2023 04:17PM Nuwellis (NUWE) Announces Appointment of Mike McCormick to its Board of Directors
Jun 5, 2023 04:15PM Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
May 24, 2023 04:15PM Baxter to Present at Jefferies Healthcare Conference
May 23, 2023 08:04AM Artivion (AORT) Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter (BAX)
May 23, 2023 08:04AM Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter
May 22, 2023 05:10PM Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 9, 2023 08:16AM Baxter (BAX) Announces CFO Transition, Maintains Outlook
May 9, 2023 08:15AM Baxter Announces CFO Transition
May 8, 2023 09:58AM Baxter (BAX) to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
May 8, 2023 09:58AM Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
May 5, 2023 09:13AM Baxter (BAX) Appoints Chris Toth CEO of Proposed Kidney Care Spinoff
May 5, 2023 09:10AM Baxter Names Chris Toth CEO of Proposed Kidney Care Spinoff
May 1, 2023 04:45PM Baxter Declares Quarterly Dividend
Apr 27, 2023 07:15AM Baxter Reports First-Quarter 2023 Results
Apr 19, 2023 04:15PM Baxter to Present at BofA Securities 2023 Health Care Conference
Apr 11, 2023 04:00PM Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO
Apr 6, 2023 04:15PM Baxter to Host First-Quarter 2023 Financial Results Conference Call for Investors
Apr 4, 2023 09:00AM Baxter Launches Zosyn Premix in US
Apr 3, 2023 09:00AM Baxter Showcases Surgical Innovations at AORN Global Surgical Conference and Expo 2023
Mar 29, 2023 09:00AM Baxter to Host Annual Meeting of Stockholders in Virtual Format
Feb 23, 2023 04:15PM Nuwellis to Present at the Oppenheimer 33rd Annual Healthcare Conference
Feb 23, 2023 08:00AM Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)
Feb 14, 2023 04:30PM Baxter Declares Quarterly Dividend
Feb 9, 2023 07:15AM Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Feb 1, 2023 08:01AM Miromatrix Medical (MIRO), Baxter (BAX) Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Feb 1, 2023 08:00AM Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Feb 1, 2023 08:00AM Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Feb 1, 2023 08:00AM Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Jan 11, 2023 04:15PM Baxter to Host Fourth-Quarter 2022 Financial Results Conference Call for Investors
Jan 6, 2023 07:02AM Baxter (BAX) announces strategic actions, to spin off the company’s Renal Care and Acute Therapies global business units
Jan 6, 2023 07:00AM Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders
Dec 29, 2022 01:34PM SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medical’s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)
Dec 12, 2022 08:30AM Baxter Named to Dow Jones Sustainability Indices for 23rd Consecutive Year
Dec 1, 2022 09:00AM Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting
Nov 16, 2022 04:15PM Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference
Nov 15, 2022 09:00AM Baxter Declares Quarterly Dividend
Nov 8, 2022 03:05PM Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
Nov 7, 2022 08:30AM Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
Oct 27, 2022 07:15AM Baxter Reports Third-Quarter 2022 Results
Sep 22, 2022 08:30AM The Baxter International Foundation Announces $3 Million in New Grants to Organizations Working to Advance Racial Justice
View More Recent Stories View Older Stories